Level/Type | Concept | Synonyms | Ordinal | Exception | Description | Code | Ordinal | Display Name | Codesystem |
|
|
|
- | Antipyretika | | | | | N02B antipyretic | | ANDERE ANALGETIKA UND ANTIPYRETIKA Product containing antipyretic | 1.2.276.0.76.5.498 2.25.24197857203266734864793317670504947440 |
- | Kortikosteroide | | | | | R03AL S02B R03AK M01BA H02 G01B 768759001 | | Sympathomimetika in Kombination mit Anticholinergika inkl. Dreifachkombinationen mit Corticosteroiden CORTICOSTEROIDE Sympathomimetika in Kombination mit Corticosteroiden oder anderen Mitteln, exkl. Anticholinergika Antiphlogistika/Antirheumatika in Kombination mit Corticosteroiden CORTICOSTEROIDE ZUR SYSTEMISCHEN ANWENDUNG ANTIINFEKTIVA/ANTISEPTIKA IN KOMBINATION MIT CORTICOSTEROIDEN Product containing steroid (product) | 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Atazanavir | | | | | J05AR23 J05AR15 J05AE08 413591007 | | Atazanavir und Ritonavir Atazanavir und Cobicistat Atazanavir Product containing atazanavir (medicinal product) | 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Darunavir | | | | | J05AR22 J05AR14 J05AE10 424096001 | | Emtricitabin, Tenofoviralafenamid, Darunavir und Cobicistat Darunavir und Cobicistat Darunavir Product containing darunavir (medicinal product) | 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Chloroquine phosphate | | | | | P01BA01 14728000 | | Chloroquin Product containing chloroquine (medicinal product) | 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Hydroxychloroquine | | | | | P01BA02 83490000 | | Hydroxychloroquin Product containing hydroxychloroquine (medicinal product) | 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Ivermectin | | | | | D11AX22 P02CF01 96138006 | | Ivermectin Ivermectin Product containing ivermectin (medicinal product) | 1.2.276.0.76.5.498 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Lopinavir/ritonavir | | | | | J05AR10 134573001 | | Lopinavir und Ritonavir Product containing lopinavir and ritonavir (medicinal product) | 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Ganciclovir | | | | | S01AD09 J05AB06 78025001 | | Ganciclovir Ganciclovir Product containing ganciclovir (medicinal product) | 1.2.276.0.76.5.498 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Oseltamivir | | | | | J05AH02 386142008 | | Oseltamivir Product containing oseltamivir (medicinal product) | 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Remdesivir | | | | | 3QKI37EEHE 870518005 | | Remdesivir Product containing remdesivir (medicinal product) | The Unique Ingredient Identifier (UNII) generated from the FDA Substance Registration System (SRS). SNOMED Clinical Terms |
- | Ribavirin | | | | | J05AP01 35063004 | | Ribavirin Product containing ribavirin (medicinal product) | 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Camostat | | | | | B02AB04 camostat | | Camostat Product containing camostat | 1.2.276.0.76.5.498 2.25.24197857203266734864793317670504947440 |
- | Favipiravir | | | | | J05AX27 favipiravir | | Favipiravir Product containing favipiravir | 1.2.276.0.76.5.498 2.25.24197857203266734864793317670504947440 |
- | Convalescent plasma | | | | | E9743 E9744 E9745 E9746 E9747 E9748 E9749 E9750 E9752 convalescent-plasma | | Apheresis CONVALESCENT PLASMA|NS/XX/<=-25C|COVID-19 Apheresis CONVALESCENT PLASMA|NS/XX/<=-25C|Methylene blue-treated|COVID-19 Apheresis CONVALESCENT PLASMA|NS/XX/<=-25C|Psoralen-treated|COVID-19 Apheresis CONVALESCENT PLASMA|NS/XX/<=-25C|Riboflavin-treated|COVID-19 Apheresis CONVALESCENT PLASMA|ACD-A/XX/<=-18C|COVID-19 Apheresis CONVALESCENT PLASMA|NS/XX/Frozen|COVID-19 CONVALESCENT PLASMA|NS/XX/Frozen|COVID-19 Liquid Apheresis CONVALESCENT PLASMA|NS/XX/refg|COVID-19 Thawed Apheresis CONVALESCENT PLASMA|ACD-A/XX/refg|COVID-19 Convalescent plasma | 2.16.840.1.113883.6.18.2.6 2.16.840.1.113883.6.18.2.6 2.16.840.1.113883.6.18.2.6 2.16.840.1.113883.6.18.2.6 2.16.840.1.113883.6.18.2.6 2.16.840.1.113883.6.18.2.6 2.16.840.1.113883.6.18.2.6 2.16.840.1.113883.6.18.2.6 2.16.840.1.113883.6.18.2.6 2.25.24197857203266734864793317670504947440 |
- | Steroids (> 0.5 mg/kg prednisone equivalents) | | | | | steroids-gt | | Steroids (> 0.5 mg/kg prednisone equivalents) | 2.25.24197857203266734864793317670504947440 |
- | Steroids (<= 0.5 mg/kg prednisone equivalents) | | | | | steroids-st | | Steroids (<= 0.5 mg/kg prednisone equivalents) | 2.25.24197857203266734864793317670504947440 |
- | Tocilizumab | | | | | 6-005.m 6-005.n L04AC07 444649004 | | Tocilizumab, intravenös Tocilizumab, subkutan Tocilizumab Product containing tocilizumab (medicinal product) | 1.2.276.0.76.5.487 1.2.276.0.76.5.487 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Sarilumab | | | | | 6-00a.g L04AC14 763522001 | | Sarilumab, parenteral Sarilumab Product containing sarilumab (medicinal product) | 1.2.276.0.76.5.487 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus) | | | | | 6-005.8 6-004.e L04AB L04AD L01XE18 S01XA18 L01XE10 L04AA18 L04AA10 D11AH01 416587008 | | Everolimus, oral Temsirolimus, parenteral Tumornekrosefaktor alpha(TNF-alpha)-Inhibitoren Calcineurin-Inhibitoren Ruxolitinib Ciclosporin Everolimus Everolimus Sirolimus Tacrolimus Product containing calcineurin inhibitor (product) | 1.2.276.0.76.5.487 1.2.276.0.76.5.487 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept) | | | | | 6-001.d 6-002.b 6-005.7 6-005.2 6-001.e 416897008 | | Adalimumab, parenteral Etanercept, parenteral Certolizumab, parenteral Golimumab, parenteral Infliximab, parenteral Product containing tumor necrosis factor alpha inhibitor (product) | 1.2.276.0.76.5.487 1.2.276.0.76.5.487 1.2.276.0.76.5.487 1.2.276.0.76.5.487 1.2.276.0.76.5.487 SNOMED Clinical Terms |
- | Il1-receptor antangonists | | | | | 6-006.7 L04AC 430817009 | | Canakinumab, parenteral Interleukin-Inhibitoren Product containing interleukin 1 receptor antagonist (product) | 1.2.276.0.76.5.487 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Ruxolitinib | | | | | 6-009.4 703779004 | | Ruxolitinib, oral Product containing ruxolitinib (medicinal product) | 1.2.276.0.76.5.487 SNOMED Clinical Terms |
- | Colchicine | | | | | M04AC01 73133000 | | Colchicin Product containing colchicine (medicinal product) | 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Interferone (any) | | | | | S01AD05 768865007 | | Interferon Product containing interferon (product) | 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | 25-Hydroxyvitamin D | | | | | A11CC06 88519001 | | Calcifediol Product containing calcifediol (medicinal product) | 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Zinc | | | | | A12CB 764877006 | | Zink Product containing zinc (medicinal product) | 1.2.276.0.76.5.498 SNOMED Clinical Terms |
- | Andere | | | | | | | | |